- Home
- PRQR vs DSM Comparison
PRQR vs DSM Comparison
Compare PRQR & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- DSM
- Stock Information
- Founded
- PRQR 2012
- DSM 1989
- Country
- PRQR Netherlands
- DSM United States
- Employees
- PRQR N/A
- DSM N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- PRQR Health Care
- DSM Finance
- Exchange
- PRQR Nasdaq
- DSM Nasdaq
- Market Cap
- PRQR 309.5M
- DSM 301.0M
- IPO Year
- PRQR 2014
- DSM N/A
- Fundamental
- Price
- PRQR $2.67
- DSM $5.75
- Analyst Decision
- PRQR Strong Buy
- DSM
- Analyst Count
- PRQR 5
- DSM 0
- Target Price
- PRQR $7.60
- DSM N/A
- AVG Volume (30 Days)
- PRQR 603.0K
- DSM 161.7K
- Earning Date
- PRQR 11-07-2024
- DSM 01-01-0001
- Dividend Yield
- PRQR N/A
- DSM 3.97%
- EPS Growth
- PRQR N/A
- DSM N/A
- EPS
- PRQR N/A
- DSM N/A
- Revenue
- PRQR $20,506,357.00
- DSM N/A
- Revenue This Year
- PRQR $235.11
- DSM N/A
- Revenue Next Year
- PRQR N/A
- DSM N/A
- P/E Ratio
- PRQR N/A
- DSM N/A
- Revenue Growth
- PRQR 306.68
- DSM N/A
- 52 Week Low
- PRQR $1.61
- DSM $4.69
- 52 Week High
- PRQR $4.62
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- PRQR 38.02
- DSM 25.70
- Support Level
- PRQR $2.48
- DSM $5.76
- Resistance Level
- PRQR $2.71
- DSM $6.18
- Average True Range (ATR)
- PRQR 0.29
- DSM 0.06
- MACD
- PRQR -0.08
- DSM -0.04
- Stochastic Oscillator
- PRQR 28.09
- DSM 4.65
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.